<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Ryan Polselli MD | Tissuepathology.com</title>
	<atom:link href="https://tissuepathology.com/Tags/ryan-polselli-md/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com</link>
	<description>Educational and informative</description>
	<lastBuildDate>Wed, 01 Feb 2017 02:41:32 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png</url>
	<title>Ryan Polselli MD | Tissuepathology.com</title>
	<link>https://tissuepathology.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Breast Imaging Company MammoLink℠ Rings in the New Year with Bold Predictions</title>
		<link>https://tissuepathology.com/2017/01/31/breast-imaging-company-mammolink%e2%84%a0-rings-in-the-new-year-with-bold-predictions/</link>
					<comments>https://tissuepathology.com/2017/01/31/breast-imaging-company-mammolink%e2%84%a0-rings-in-the-new-year-with-bold-predictions/#comments</comments>
		
		<dc:creator><![CDATA[Dr. Keith J. Kaplan]]></dc:creator>
		<pubDate>Wed, 01 Feb 2017 02:41:18 +0000</pubDate>
				<category><![CDATA[Anatomic Pathology]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[Clinical Laboratories]]></category>
		<category><![CDATA[Clinical Pathology]]></category>
		<category><![CDATA[Device Manufacturers]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[Breast Cancer Screening]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Mammogram]]></category>
		<category><![CDATA[Mammography]]></category>
		<category><![CDATA[Mammography Screening Guidelines]]></category>
		<category><![CDATA[MammoLink]]></category>
		<category><![CDATA[Ryan Polselli MD]]></category>
		<guid isPermaLink="false">http://tissuepathology.com/?p=11408</guid>

					<description><![CDATA[<p>This looks interesting.  Wonder if this will generate more mammograms, more abnormal mammograms and more breast biopsies with potential to detect disease at an earlier stage. Does sound like a bold prediction putting the technology at point of care in primary care and ob-gyn offices.  Startup breast imaging company, MammoLink℠, is improving breast cancer screening by [&#8230;]</p>
The post <a href="https://tissuepathology.com/2017/01/31/breast-imaging-company-mammolink%e2%84%a0-rings-in-the-new-year-with-bold-predictions/">Breast Imaging Company MammoLink℠ Rings in the New Year with Bold Predictions</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
					<wfw:commentRss>https://tissuepathology.com/2017/01/31/breast-imaging-company-mammolink%e2%84%a0-rings-in-the-new-year-with-bold-predictions/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
	</channel>
</rss>
